Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $577.9900 (0.47%) ($577.9900 - $577.9900) on Tue. Jul. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.39% (three month average) | RSI | 72 | Latest Price | $577.9900(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(37%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.695% in a week (0% probabilities). VIXM(-21%) UUP(-6%) TBT(-6%) VXX(-5%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.695% (StdDev 1.39%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $578.91(-0.16%) | 10 Day Moving Average | $574.29(0.64%) | 20 Day Moving Average | $556.28(3.9%) | To recent high | -1.5% | To recent low | 20.8% | Market Cap | $61.284b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |